Angiotensin II receptor blockers is associated a decreased left ventricular fibrosis in patients with obstructive hypertrophic cardiomyopathy

25 April 2024 (12:45 - 13:45)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Changrong Nie

Fuwai Hospital Chinese Academy of Medical Sciences, Beijing (China)

10 More presentations in this session

Presentation thumbnail

Are patients with hypertrophic cardiomyopathy given appropriate advice on exercise at a central London inherited cardiac conditions outpatient service?

Doctor K. Sonthikaew (Bangkok, TH)

Abstract Slides

Presentation thumbnail

Cardiac magnetic resonance imaging aids in differentiating dilated cardiomyopathy from the athlete's heart

Mr J. Daems (Amsterdam, NL)

Abstract Slides

Presentation thumbnail

Optimising screening of intermediate to high-risk asymptomatic sportsmen with exercise electrocardiogram.

Doctor D. Hupin (Saint-Etienne, FR)

Abstract Slides

Presentation thumbnail

Cardiopulmonary exercise testing in athletes and non-athletes with hypertrophic cardiomyopathy

Doctor J. Scicluna (Msida, MT)

Abstract Slides

Presentation thumbnail

Interpretation of athlete's ECG in a pediatric population using the International Criteria

Doctor F. Graziano (Padova, IT)

Abstract Slides

Access the full session

Session thumbnail

Hypertrophic cardiomyopathy: diagnosis and management

The Event

Event poster

ESC Preventive Cardiology 2024

25 April 2024 12:45 CET

You may be interested in

Congress Session

Novel drug therapies in hypertension: new kids on the block

Congress Presentation

RNA therapeutics for treatment of hypertension

Congress Session

Hypertension with cardiometabolic comorbidities: which drugs to select and which to avoid

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources